EP0860433B1 — Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same
Assigned to Kirin Brewery Co Ltd · Expires 2002-07-03 · 24y expired
What this patent protects
Novel quinoline derivatives and quinazoline derivatives represented by general formula (I) which have an inhibitory effect on the autophosphorylation of growth factor receptors originating in platelets and pharmaceutically acceptable salts thereof; pharmaceutical compositions con…
USPTO Abstract
Novel quinoline derivatives and quinazoline derivatives represented by general formula (I) which have an inhibitory effect on the autophosphorylation of growth factor receptors originating in platelets and pharmaceutically acceptable salts thereof; pharmaceutical compositions containing these compounds; and a method for treating diseases relating to the abnormal proliferation of cells such as the proliferation of tumors, wherein R1 and R2 represent each H or C1-4 alkyl, or R1 and R2 together form C1-3 alkylene; X represents O, S or CH2; W represents CH or N; and Q represents substituted aryl or substituted heteroaryl.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.